Physician profile
Stacey Sensor
NPI 1588658579
$12,450.61
in general payments reported to CMS, 2019-2025
28 companies · $4,371 in 2025
The $4,371 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $220 · 2021: $181 · 2022: $3,550 · 2023: $3,379 · 2024: $345 · 2025: $4,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,090 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,089.99 |
| Food and Beverage | $1,004.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,177.00 | 2022-2025 | Davinci Xi |
| Medtronic, INC. | $594.91 | 2021-2024 | Interstim, Truclear |
| Coloplast Corp | $293.71 | 2021-2024 | Altis |
| Abbvie INC. | $213.18 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Minerva Surgical, INC | $143.60 | 2019 | |
| Astellas Pharma US INC | $123.34 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $88.13 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $79.95 | 2019-2024 | |
| Aspira Women'S Health INC | $68.95 | 2019-2022 | |
| Biogen, INC. | $65.44 | 2024 | Zurzuvae |
| Therapeuticsmd, INC. | $60.52 | 2019-2020 | |
| Exact Sciences Corporation | $55.07 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $48.39 | 2025 | Paragard T 380a |
| Pfizer INC. | $42.49 | 2024 | |
| Lupin INC. | $41.82 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $41.22 | 2024 | Arista Ah Flexitip |
| Exeltis, USA INC. | $35.85 | 2020 | |
| Becton, Dickinson and Company | $35.29 | 2023 | Bd Affirm Vpiii Microbial Identification Test, Bd Onclarity |
| Organon LLC | $34.84 | 2023-2024 | Nuvaring, Nexplanon |
| Millicent US INC | $29.37 | 2020 | |
| Duchesnay USA Incorporated | $27.85 | 2019 | |
| Novo Nordisk INC | $27.80 | 2020 | |
| Mylan Pharmaceuticals INC. | $26.76 | 2020 | |
| Avion Pharmaceuticals | $25.57 | 2019 | |
| Conmed Corporation | $23.27 | 2023 | Airseal |
| Karl Storz Endoscopy-America | $18.01 | 2019 | |
| Ethicon US, LLC | $15.24 | 2024 | Surgicel Nu-Knit |
| Amag Pharmaceuticals, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Sensor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.